bezafibrate has been researched along with Diabetes Mellitus, Type 1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, U; Fisman, EZ; Goldenberg, I; Klempfner, R; Matetzky, S; Shemesh, J; Tenenbaum, A | 1 |
| Chiang, HL; Chou, TY; Ho, LT; Kwok, CF; Tsai, H | 1 |
| Anderson, DC; Arrol, S; Bhatagnar, D; Durrington, PN; Ishola, M; Mackness, M; Winocour, PH | 1 |
| Bhatnagar, D; Durrington, PN; Winocour, PH | 1 |
| Kostner, GM; Schernthaner, G | 1 |
2 trial(s) available for bezafibrate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
Topics: Adolescent; Adult; Aged; Bezafibrate; Cholesterol; Diabetes Mellitus, Type 1; Double-Blind Method; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Triglycerides | 1992 |
Bezafibrate retard in patients with insulin-dependent diabetes: effect on serum lipoproteins, fibrinogen, and glycemic control.
Topics: Adolescent; Adult; Aged; Bezafibrate; Blood Glucose; Diabetes Mellitus, Type 1; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged | 1990 |
4 other study(ies) available for bezafibrate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Bezafibrate; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Israel; Male; Middle Aged; Morbidity; Prospective Studies; Survival Rate; Treatment Outcome | 2014 |
A therapeutic trial of bezafibrate on patients with hyperlipidemia with or without diabetes mellitus.
Topics: Administration, Oral; Bezafibrate; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Evaluation; Glycated Hemoglobin; Humans; Hyperlipidemias; Random Allocation; Triglycerides | 1984 |
[Diabetes and hyperlipidemia. Increased coronary risk can be prevented].
Topics: Bezafibrate; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias | 1988 |
Apolipoproteins in diabetes mellitus.
Topics: Adult; Apolipoproteins; Bezafibrate; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Insulin; Lipoproteins; Male | 1985 |